Chengda Pharmaceutical: Legal Opinion of Beijing Zhonglun Wende (Hangzhou) Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Chengda Pharmaceutical Co., Ltd.

SZSI · Jan 12

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.